ly 171883 has been researched along with Hemorrhagic Shock in 1 studies
LY 171883: structure in first source; leukotriene receptor antagonist
tomelukast : A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, JP | 1 |
| Beck, LD | 1 |
| Briglia, FA | 1 |
| Hock, CE | 1 |
1 other study available for ly 171883 and Hemorrhagic Shock
| Article | Year |
|---|---|
Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
Topics: Acetophenones; Animals; Blood Pressure; Blood Volume; Bridged Bicyclo Compounds, Heterocyclic; Cathe | 1995 |